PVLA
Price
$105.18
Change
+$1.64 (+1.58%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
1.25B
Intraday BUY SELL Signals
TPST
Price
$2.55
Change
-$0.18 (-6.59%)
Updated
Jan 14 closing price
Capitalization
12.56M
Intraday BUY SELL Signals
Interact to see
Advertisement

PVLA vs TPST

Header iconPVLA vs TPST Comparison
Open Charts PVLA vs TPSTBanner chart's image
Palvella Therapeutics
Price$105.18
Change+$1.64 (+1.58%)
Volume$1.56K
Capitalization1.25B
Tempest Therapeutics
Price$2.55
Change-$0.18 (-6.59%)
Volume$64.41K
Capitalization12.56M
PVLA vs TPST Comparison Chart in %
PVLA
Daily Signal:
Gain/Loss:
TPST
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PVLA vs. TPST commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PVLA is a Hold and TPST is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (PVLA: $105.30 vs. TPST: $2.55)
Brand notoriety: PVLA and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PVLA: 32% vs. TPST: 44%
Market capitalization -- PVLA: $1.25B vs. TPST: $12.56M
PVLA [@Biotechnology] is valued at $1.25B. TPST’s [@Biotechnology] market capitalization is $12.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PVLA’s FA Score shows that 1 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • PVLA’s FA Score: 1 green, 4 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, PVLA is a better buy in the long-term than TPST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PVLA’s TA Score shows that 5 TA indicator(s) are bullish while TPST’s TA Score has 4 bullish TA indicator(s).

  • PVLA’s TA Score: 5 bullish, 3 bearish.
  • TPST’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PVLA is a better buy in the short-term than TPST.

Price Growth

PVLA (@Biotechnology) experienced а +4.23% price change this week, while TPST (@Biotechnology) price change was -9.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PVLA($1.25B) has a higher market cap than TPST($12.6M). PVLA YTD gains are higher at: -1.080 vs. TPST (-11.150). PVLA has higher annual earnings (EBITDA): -27.57M vs. TPST (-35.35M). PVLA has more cash in the bank: 63.6M vs. TPST (7.51M). PVLA (0) and TPST (0) have equivalent revenues.
PVLATPSTPVLA / TPST
Capitalization1.25B12.6M9,889%
EBITDA-27.57M-35.35M78%
Gain YTD-1.080-11.15010%
P/E Ratio14.22N/A-
Revenue00-
Total Cash63.6M7.51M846%
Total DebtN/A8.41M-
FUNDAMENTALS RATINGS
PVLA vs TPST: Fundamental Ratings
PVLA
TPST
OUTLOOK RATING
1..100
7515
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
37
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3493
P/E GROWTH RATING
1..100
1289
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TPST's Valuation (37) in the Pharmaceuticals Major industry is somewhat better than the same rating for PVLA (78) in the null industry. This means that TPST’s stock grew somewhat faster than PVLA’s over the last 12 months.

TPST's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as PVLA (100) in the null industry. This means that TPST’s stock grew similarly to PVLA’s over the last 12 months.

PVLA's SMR Rating (98) in the null industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that PVLA’s stock grew similarly to TPST’s over the last 12 months.

PVLA's Price Growth Rating (34) in the null industry is somewhat better than the same rating for TPST (93) in the Pharmaceuticals Major industry. This means that PVLA’s stock grew somewhat faster than TPST’s over the last 12 months.

PVLA's P/E Growth Rating (12) in the null industry is significantly better than the same rating for TPST (89) in the Pharmaceuticals Major industry. This means that PVLA’s stock grew significantly faster than TPST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PVLATPST
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
PVLA
Daily Signal:
Gain/Loss:
TPST
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LADVX36.990.21
+0.57%
Lord Abbett Developing Growth R6
KGIRX17.750.07
+0.40%
Kopernik International Investor
MOWNX21.400.04
+0.19%
Moerus Worldwide Value N
DEMCX30.49-0.07
-0.23%
Nomura Emerging Markets C
MEIFX13.19-0.07
-0.53%
Meridian Hedged Equity Legacy

PVLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PVLA has been loosely correlated with DRMA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PVLA jumps, then DRMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVLA
1D Price
Change %
PVLA100%
+3.04%
DRMA - PVLA
42%
Loosely correlated
+16.48%
TPST - PVLA
35%
Loosely correlated
-4.55%
OCUL - PVLA
35%
Loosely correlated
-2.43%
LEGN - PVLA
35%
Loosely correlated
-4.77%
FHTX - PVLA
35%
Loosely correlated
+4.70%
More

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been loosely correlated with AGIO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if TPST jumps, then AGIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
-6.59%
AGIO - TPST
56%
Loosely correlated
+3.35%
PHIO - TPST
49%
Loosely correlated
-5.08%
NRIX - TPST
40%
Loosely correlated
+0.58%
PVLA - TPST
35%
Loosely correlated
+1.70%
GLMD - TPST
35%
Loosely correlated
-0.83%
More